AGA clinical practice update on the diagnosis and management of atrophic gastritis: expert review
SC Shah, MB Piazuelo, EJ Kuipers, D Li - Gastroenterology, 2021 - Elsevier
Description The purpose of this Clinical Practice Update Expert Review is to provide
clinicians with guidance on the diagnosis and management of atrophic gastritis, a common …
clinicians with guidance on the diagnosis and management of atrophic gastritis, a common …
Interventional gastroenterology in oncology
Cancer is one of the foremost health problems worldwide and is among the leading causes
of death in the United States. Gastrointestinal tract cancers account for almost one third of …
of death in the United States. Gastrointestinal tract cancers account for almost one third of …
Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus
Objective A global consensus meeting was held to review current evidence and knowledge
gaps and propose collaborative studies on population-wide screening and eradication of …
gaps and propose collaborative studies on population-wide screening and eradication of …
[HTML][HTML] Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial
Summary Background Treatment of dysplastic Barrett's oesophagus prevents progression to
adenocarcinoma; however, the optimal diagnostic strategy for Barrett's oesophagus is …
adenocarcinoma; however, the optimal diagnostic strategy for Barrett's oesophagus is …
Helicobacter pylori infection, its laboratory diagnosis, and antimicrobial resistance: a perspective of clinical relevance
Despite the recent decrease in overall prevalence of Helicobacter pylori infection, morbidity
and mortality rates associated with gastric cancer remain high. The antimicrobial resistance …
and mortality rates associated with gastric cancer remain high. The antimicrobial resistance …
Gastric cancer: where are we heading?
P Petryszyn, N Chapelle, T Matysiak-Budnik - Digestive Diseases, 2020 - karger.com
Background: Despite its decreasing incidence, gastric cancer (GC) remains one of the
leading cancers in the world and an important global healthcare problem due to its overall …
leading cancers in the world and an important global healthcare problem due to its overall …
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
P Malfertheiner, F Megraud, T Rokkas, JP Gisbert… - Gut, 2022 - gut.bmj.com
Helicobacter pylori Infection is formally recognised as an infectious disease, an entity that is
now included in the International Classification of Diseases 11th Revision. This in principle …
now included in the International Classification of Diseases 11th Revision. This in principle …
Gastric cancer: emerging trends in prevention, diagnosis, and treatment
DA Norwood, E Montalvan-Sanchez… - Gastroenterology …, 2022 - gastro.theclinics.com
Gastric adenocarcinoma (GC) is the third leading cause of global cancer mortality, and the
leading infection-associated cancer with more than 1 million incident cases annually and …
leading infection-associated cancer with more than 1 million incident cases annually and …
Helicobacter pylori: A Review of Current Diagnostic and Management Strategies
B Guevara, AG Cogdill - Digestive diseases and sciences, 2020 - Springer
As one of the most prevalent infections globally, Helicobacter pylori (H. pylori) continues to
present diagnostic and therapeutic challenges for clinicians worldwide. Diagnostically, the …
present diagnostic and therapeutic challenges for clinicians worldwide. Diagnostically, the …
The Colombian chemoprevention trial: 20-year follow-up of a cohort of patients with gastric precancerous lesions
MB Piazuelo, LE Bravo, RM Mera, MC Camargo… - Gastroenterology, 2021 - Elsevier
Background & Aims Helicobacter pylori eradication and endoscopic surveillance of gastric
precancerous lesions are strategies to reduce gastric cancer (GC) risk. To our knowledge …
precancerous lesions are strategies to reduce gastric cancer (GC) risk. To our knowledge …